Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats

T. Hasegawa, M. Nadai, S. Haghgoo, K. I. Yamaki, K. Takagi, Toshitaka Nabeshima

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The effect of a new quinolone, T-3761, on the pharmacokinetics and metabolism of theophylline was investigated with rats. T-3761 at a high dose (20 mg/kg of body weight) was injected intravenously 10 min before an intravenous administration of theophylline (10 mg/kg). The presence of T- 3761 slightly delayed the disappearance of theophylline from plasma. Parameters related to the pharmacokinetic interaction between theophylline and T-3761 were estimated by noncompartmental methods. A significant decrease (approximately 25%) in the systemic clearance of theophylline was observed in the presence of T-3761. However, no significant changes between the control group and the T-3761-treated groups in the volume of distribution at a steady state were observed. Pretreatment with T-3761 increased the urinary excretion of unchanged theophylline (by approximately 25%) and decreased the nonrenal clearances (by approximately 30%), indicating that T-3761 inhibits the metabolism of theophylline. These findings suggest that T-3761 at the dose used in this study affects the pharmacokinetics and metabolism of theophylline.

Original languageEnglish
Pages (from-to)2138-2140
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume39
Issue number9
DOIs
Publication statusPublished - 01-01-1995
Externally publishedYes

Fingerprint

Quinolones
Theophylline
Pharmacokinetics
pazufloxacin
Intravenous Administration
Body Weight
Control Groups

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Hasegawa, T. ; Nadai, M. ; Haghgoo, S. ; Yamaki, K. I. ; Takagi, K. ; Nabeshima, Toshitaka. / Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats. In: Antimicrobial Agents and Chemotherapy. 1995 ; Vol. 39, No. 9. pp. 2138-2140.
@article{5b2d9aa9402f433b939b181b582cb0ab,
title = "Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats",
abstract = "The effect of a new quinolone, T-3761, on the pharmacokinetics and metabolism of theophylline was investigated with rats. T-3761 at a high dose (20 mg/kg of body weight) was injected intravenously 10 min before an intravenous administration of theophylline (10 mg/kg). The presence of T- 3761 slightly delayed the disappearance of theophylline from plasma. Parameters related to the pharmacokinetic interaction between theophylline and T-3761 were estimated by noncompartmental methods. A significant decrease (approximately 25{\%}) in the systemic clearance of theophylline was observed in the presence of T-3761. However, no significant changes between the control group and the T-3761-treated groups in the volume of distribution at a steady state were observed. Pretreatment with T-3761 increased the urinary excretion of unchanged theophylline (by approximately 25{\%}) and decreased the nonrenal clearances (by approximately 30{\%}), indicating that T-3761 inhibits the metabolism of theophylline. These findings suggest that T-3761 at the dose used in this study affects the pharmacokinetics and metabolism of theophylline.",
author = "T. Hasegawa and M. Nadai and S. Haghgoo and Yamaki, {K. I.} and K. Takagi and Toshitaka Nabeshima",
year = "1995",
month = "1",
day = "1",
doi = "10.1128/AAC.39.9.2138",
language = "English",
volume = "39",
pages = "2138--2140",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "9",

}

Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats. / Hasegawa, T.; Nadai, M.; Haghgoo, S.; Yamaki, K. I.; Takagi, K.; Nabeshima, Toshitaka.

In: Antimicrobial Agents and Chemotherapy, Vol. 39, No. 9, 01.01.1995, p. 2138-2140.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats

AU - Hasegawa, T.

AU - Nadai, M.

AU - Haghgoo, S.

AU - Yamaki, K. I.

AU - Takagi, K.

AU - Nabeshima, Toshitaka

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The effect of a new quinolone, T-3761, on the pharmacokinetics and metabolism of theophylline was investigated with rats. T-3761 at a high dose (20 mg/kg of body weight) was injected intravenously 10 min before an intravenous administration of theophylline (10 mg/kg). The presence of T- 3761 slightly delayed the disappearance of theophylline from plasma. Parameters related to the pharmacokinetic interaction between theophylline and T-3761 were estimated by noncompartmental methods. A significant decrease (approximately 25%) in the systemic clearance of theophylline was observed in the presence of T-3761. However, no significant changes between the control group and the T-3761-treated groups in the volume of distribution at a steady state were observed. Pretreatment with T-3761 increased the urinary excretion of unchanged theophylline (by approximately 25%) and decreased the nonrenal clearances (by approximately 30%), indicating that T-3761 inhibits the metabolism of theophylline. These findings suggest that T-3761 at the dose used in this study affects the pharmacokinetics and metabolism of theophylline.

AB - The effect of a new quinolone, T-3761, on the pharmacokinetics and metabolism of theophylline was investigated with rats. T-3761 at a high dose (20 mg/kg of body weight) was injected intravenously 10 min before an intravenous administration of theophylline (10 mg/kg). The presence of T- 3761 slightly delayed the disappearance of theophylline from plasma. Parameters related to the pharmacokinetic interaction between theophylline and T-3761 were estimated by noncompartmental methods. A significant decrease (approximately 25%) in the systemic clearance of theophylline was observed in the presence of T-3761. However, no significant changes between the control group and the T-3761-treated groups in the volume of distribution at a steady state were observed. Pretreatment with T-3761 increased the urinary excretion of unchanged theophylline (by approximately 25%) and decreased the nonrenal clearances (by approximately 30%), indicating that T-3761 inhibits the metabolism of theophylline. These findings suggest that T-3761 at the dose used in this study affects the pharmacokinetics and metabolism of theophylline.

UR - http://www.scopus.com/inward/record.url?scp=0029113104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029113104&partnerID=8YFLogxK

U2 - 10.1128/AAC.39.9.2138

DO - 10.1128/AAC.39.9.2138

M3 - Article

C2 - 8540732

AN - SCOPUS:0029113104

VL - 39

SP - 2138

EP - 2140

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 9

ER -